PRPH 0.78 (-45.45%)
US74345W1080Drug ManufacturersDrug Manufacturers - Specialty & Generic

ProPhase Labs (PRPH) Competitor Comparison

We are evaluating the key criteria listed to compare ProPhase Labs (PRPH) against its competitors in the Drug Manufacturers - Specialty & Generic industry.

Performance 3 years - PRPH ranking 44 / 54

These are the competitors of ProPhase Labs in the industry Drug Manufacturers - Specialty & Generic ranked by performance 3 years
1. Harrow Health HROW
338.68
2. Amphastar Pharmaceuticals AMPH
140.47
3. Teva Pharmaceutical Industries TEVA
86.38
4. Evolus EOLS
81.43
5. Amneal Pharmaceuticals AMRX
71.18
6. Collegium Pharmaceutical COLL
68.47
7. Avadel Pharmaceuticals AVDL
57.98
8. Vifor Pharma G2AB.F
39.09
9. Alvotech ALVO
33.58
10. PetIQ PETQ
26.14
11. ANI Pharmaceuticals ANIP
22.86
12. Kolinpharma KIP.MI
17.3
13. Alimera Sciences ALIM
15.9
14. Supernus Pharmaceuticals SUPN
13.59
15. Phibro Animal Health PAHC
6.71
16. Kamada KMDA
3.45
17. Zoetis ZTS
-18.93
18. Journey Medical DERM
-35.06
19. Taro Pharmaceutical Industries TARO
-41.5
20. Perrigo PRGO
-43.37
21. Catalent CTLT
-51.9
22. Linc LNC
-52.4
23. Green Thumb Industries R9U2.F
-54.22
24. Elanco Animal Health ELAN
-58.8
25. Cumberland Pharmaceuticals CPIX
-60.73
26. Ironwood Pharmaceuticals IRWD
-61.55
27. Zynerba Pharmaceuticals ZYNE
-64.48
28. Emergent BioSolutions EBS
-64.78
29. Cronos Group CRON
-64.79
30. Societal CDMO SCTL
-65.73
31. Regencell Bioscience Holdings RGC
-66.11
32. Bausch Health Companies BHC
-66.64
33. Embecta EMBC
-67.63
34. Alpha Teknova TKNO
-69.18
35. Pacira BioSciences PCRX
-70.36
36. Organogenesis Holdings ORGO
-71.1
37. OptiNose OPTN
-73.58
38. SCYNEXIS SCYX
-77.22
39. Jupiter Wellness JUPW
-80
40. Curaleaf Holdings CURLF
-80.62
41. Solid Biosciences SLDB
-83.2
42. Procaps Group PROC
-84.34
43. Tilray Brands TLRY
-86.13
44. ProPhase Labs PRPH
-86.78
45. Relmada Therapeutics RLMD
-87.59
46. Ascend Wellness Holdings AAWH
-90
47. Theratechnologies THTX
-91
48. Ayr Wellness 3KJB.F
-94.43
49. Neoleukin Therapeutics NLTX
-94.43
50. Universe Pharmaceuticals UPC
-96.27
51. Eagle Pharmaceuticals EGRX
-98.42
52. Flora Growth FLGC
-98.62
53. Biofrontera BFRI
-98.78
54. Clever Leaves Holdings CLVR
-100

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.